Euxanthone Attenuates Aβ1-42-Induced Oxidative Stress and Apoptosis by Triggering Autophagy

J Mol Neurosci. 2018 Dec;66(4):512-523. doi: 10.1007/s12031-018-1175-2. Epub 2018 Oct 22.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder and is characterized by the deposition of β-Amyloid (Aβ) plaques which contribute to its pathology. The present study was aimed at exploring the protective effects of euxanthone against Aβ-induced neurotoxicity both in vivo and in vitro. We found that euxanthone significantly attenuated Aβ1-42-induced memory and spatial learning dysfunction and also significantly reversed Aβ1-42-induced neuronal apoptosis and autophagy in the hippocampal region. Euxanthone also protected the neuroblastic PC12 cells against Aβ1-42-induced oxidative stress and apoptosis by inducing autophagy. In conclusion, euxanthone exerts its neuroprotective effect against Aβ1-42 by inducing autophagy, indicating its potential therapeutic role in AD.

Keywords: Alzheimer’s disease; Autophagy; Euxanthone.

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Amyloid beta-Peptides / toxicity
  • Animals
  • Antioxidants / pharmacology*
  • Antioxidants / therapeutic use
  • Apoptosis*
  • Autophagy*
  • Hippocampus / cytology
  • Hippocampus / drug effects
  • Male
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Oxidative Stress
  • PC12 Cells
  • Peptide Fragments / toxicity
  • Rats
  • Rats, Sprague-Dawley
  • Xanthones / pharmacology*
  • Xanthones / therapeutic use

Substances

  • Amyloid beta-Peptides
  • Antioxidants
  • Neuroprotective Agents
  • Peptide Fragments
  • Xanthones
  • amyloid beta-protein (1-42)
  • euxanthone